Nintedanib N-Acetyl Impurity with CAS No: 2380229-45-6 is an impurity standard of Nintedanib. Nintedanib is a tyrosine kinase inhibitor used for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and debilitating lung disease. Its chemical structure includes a pyridine and indole moiety. Nintedanib exerts its therapeutic effects by inhibiting multiple receptor tyrosine kinases, including those involved in the pathways of platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). By targeting these pathways, nintedanib helps to slow down the progression of fibrosis in the lungs and preserve lung function. It is administered orally and is often part of a comprehensive treatment plan for individuals with IPF. Buy high quality Nintedanib N-Acetyl Impurity from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Nintedanib N-Acetyl Impurity
Nintedanib N-Acetyl Impurity
CAT. No.
CP-N24002
CAS. No.
2380229-45-6
Mol. F.
C33H35N5O5
Mol. Wt.
581.67
Stock Status
Custom Synthesis
Category:
Impurity Standards
Synonyms:
NA
Chemical Name:
Methyl (Z)-1-acetyl-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate
Request for Quotation : Nintedanib N-Acetyl Impurity
Search by Keywords - Buy 2380229-45-6 | Purchase 2380229-45-6 | Order 2380229-45-6 | Enquire 2380229-45-6 | Price of 2380229-45-6 | 2380229-45-6 Cost | 2380229-45-6 Supplier | 2380229-45-6 Distributor | 2380229-45-6 Manufacturer | 2380229-45-6 Exporter | Nintedanib N-Acetyl Impurity for Method Validation | Nintedanib N-Acetyl Impurity for ANDA Filing | Nintedanib N-Acetyl Impurity for Forced Degradation Studies | Nintedanib N-Acetyl Impurity Identification Standards | Nintedanib N-Acetyl Impurity for DMF Filing | Nintedanib
We have received your request successfully. Thank you for your interest in our product line. To
provide you with a Quotation, Our Sales team will contact you shortly.
Chemicea Pharmaceuticals Pvt. Ltd.
Thank You
You will receive blog content, featuring scientific research and exclusive promotions.